To study a possible functional relevance of FPR-activation in AD, we used APP/PS1 double-transgenic and WT mice to test the effect of FPR-modulation via the intraperitoneal injection of different FPR ligands. This evidence concerns the gene PSEN1 and Alzheimer disease.